In 2011, the Bohn lab observed antinociception in opposition to equally chemically induced and inflammation-derived discomfort, and experiments indicated insufficient opioid receptor modulation, but ended up struggling to define a particular target. "We confirmed that conolidine binds to the newly recognized opioid receptor ACKR3, although displaying no affinity for https://johng394eul1.bloguerosa.com/profile